Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study.
Gayet-Ageron A, Ben Messaoud K, Richards M, Jaksic C, Gobeill J, Liyanapathirana J, Mottin L, Naderi N, Ruch P, Mariot Z, Calmy A, Friedman J, Leibovici L, Schroter S. Gayet-Ageron A, et al. Among authors: calmy a. BMJ Evid Based Med. 2024 Dec 25:bmjebm-2024-113083. doi: 10.1136/bmjebm-2024-113083. Online ahead of print. BMJ Evid Based Med. 2024. PMID: 39721743 Free article.
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.
Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Boyer S, et al. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9. Pharmacoecon Open. 2020. PMID: 31273686 Free PMC article.
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV.
Thoueille P, Saldanha SA, Schaller F, Choong E, Veuve F, Munting A, Cavassini M, Braun D, Günthard HF, Duran Ramirez JJ, Surial B, Furrer H, Rauch A, Ustero P, Calmy A, Stöckle M, Di Benedetto C, Bernasconi E, Schmid P, Marzolini C, Girardin FR, Buclin T, Decosterd LA, Guidi M. Thoueille P, et al. Among authors: calmy a. Front Pharmacol. 2024 Nov 15;15:1437400. doi: 10.3389/fphar.2024.1437400. eCollection 2024. Front Pharmacol. 2024. PMID: 39619609 Free PMC article.
Booster-free anti-retroviral therapy for persons living with HIV and multidrug resistance (B-Free): protocol for a multicentre, multistage, randomised, controlled, non-inferiority trial.
Ballif M, Braun D, Calmy A, Bernasconi E, Cavassini M, Tissot F, Stoeckle M, Schmid P, Fux CA, Van der Valk M, Brinkman K, Mudrikova T, Bonnet F, Leleux O, Saúde M, Hirter D, Schwab N, Limacher A, Rintelen F, Kouyos R, Haerry D, Zambrano SC, Egloff M, Akre C, Peytremann-Bridevaux I, Rauch A, Wandeler G, Surial B. Ballif M, et al. Among authors: calmy a. BMJ Open. 2024 Nov 21;14(11):e094912. doi: 10.1136/bmjopen-2024-094912. BMJ Open. 2024. PMID: 39578038 Free PMC article.
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa.
Papot E, Tovar-Sanchez T, Woods J, Thaurignac G, Eriobu N, Borok M, Kaplan R, Avihingsanon A, Azwa I, Grinsztejng B, Kumarasamy N, Sokhela S, Mpoudi-Etame M, Arriaga M, Jacoby S, Matthews GV, Losso MH, Khoo S, Calmy A, Kouanfack C, Ayouba A, Petoumenos K, Venter WDF, Delaporte E, Polizzotto MN; COHIVE study group (COHIVE consortium includes ADVANCE, DolPHIN2, D2EFT and NAMSAL study groups). Papot E, et al. Among authors: calmy a. AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068. Online ahead of print. AIDS. 2024. PMID: 39576151
Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV.
Tepekule B, Jörimann L, Schenkel CD, Opitz L, Tschumi J, Wolfensberger R, Neumann K, Kusejko K, Zeeb M, Boeck L, Kälin M, Notter J, Furrer H, Hoffmann M, Hirsch HH, Calmy A, Cavassini M, Labhardt ND, Bernasconi E, Oesch G, Metzner KJ, Braun DL, Günthard HF, Kouyos RD, Duffy F, Nemeth J; Swiss HIV Cohort Study. Tepekule B, et al. Among authors: calmy a. iScience. 2024 Oct 21;27(11):111228. doi: 10.1016/j.isci.2024.111228. eCollection 2024 Nov 15. iScience. 2024. PMID: 39555417 Free PMC article.
Patient and public involvement in HIV research: a mapping review and development of an online evidence map.
Jackson-Perry D, Cart-Richter E, Haerry D, Ahmeti L, Bieri A, Calmy A, Ballif M, Pasin C, Notter J, Amstutz A; Swiss HIV Cohort Study Young Researchers’ Group, and the Swiss HIV Cohort Study. Jackson-Perry D, et al. Among authors: calmy a. J Int AIDS Soc. 2024 Nov;27(11):e26385. doi: 10.1002/jia2.26385. J Int AIDS Soc. 2024. PMID: 39528422 Free PMC article. Review.
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.
Marinosci A, Sculier D, Wandeler G, Yerly S, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Decosterd L, Günthard HF, Schmid P, Limacher A, Branca M, Calmy A; Swiss HIV Cohort Study. Marinosci A, et al. Among authors: calmy a. Open Forum Infect Dis. 2024 Oct 16;11(11):ofae618. doi: 10.1093/ofid/ofae618. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39507885 Free PMC article. Clinical Trial.
667 results